1. Home
  2. UMAC vs LFCR Comparison

UMAC vs LFCR Comparison

Compare UMAC & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UMAC
  • LFCR
  • Stock Information
  • Founded
  • UMAC 2019
  • LFCR 1986
  • Country
  • UMAC United States
  • LFCR United States
  • Employees
  • UMAC N/A
  • LFCR N/A
  • Industry
  • UMAC
  • LFCR Biotechnology: Pharmaceutical Preparations
  • Sector
  • UMAC
  • LFCR Health Care
  • Exchange
  • UMAC Nasdaq
  • LFCR Nasdaq
  • Market Cap
  • UMAC 267.7M
  • LFCR 255.1M
  • IPO Year
  • UMAC 2024
  • LFCR N/A
  • Fundamental
  • Price
  • UMAC $13.03
  • LFCR $6.83
  • Analyst Decision
  • UMAC Strong Buy
  • LFCR Buy
  • Analyst Count
  • UMAC 3
  • LFCR 4
  • Target Price
  • UMAC $19.33
  • LFCR $8.00
  • AVG Volume (30 Days)
  • UMAC 4.5M
  • LFCR 200.5K
  • Earning Date
  • UMAC 11-13-2025
  • LFCR 10-03-2025
  • Dividend Yield
  • UMAC N/A
  • LFCR N/A
  • EPS Growth
  • UMAC N/A
  • LFCR N/A
  • EPS
  • UMAC N/A
  • LFCR N/A
  • Revenue
  • UMAC $7,701,550.00
  • LFCR $128,867,000.00
  • Revenue This Year
  • UMAC $86.94
  • LFCR $4.72
  • Revenue Next Year
  • UMAC $118.95
  • LFCR $10.97
  • P/E Ratio
  • UMAC N/A
  • LFCR N/A
  • Revenue Growth
  • UMAC 279.38
  • LFCR 0.47
  • 52 Week Low
  • UMAC $1.43
  • LFCR $4.76
  • 52 Week High
  • UMAC $23.62
  • LFCR $8.85
  • Technical
  • Relative Strength Index (RSI)
  • UMAC 51.49
  • LFCR 47.35
  • Support Level
  • UMAC $11.11
  • LFCR $6.70
  • Resistance Level
  • UMAC $13.18
  • LFCR $6.94
  • Average True Range (ATR)
  • UMAC 1.63
  • LFCR 0.24
  • MACD
  • UMAC -0.37
  • LFCR 0.04
  • Stochastic Oscillator
  • UMAC 37.51
  • LFCR 82.79

About UMAC Unusual Machines Inc. Common Stock

Unusual Machines Inc is engaged in serving the American drone industry by building and selling drone components.

About LFCR Lifecore Biomedical Inc.

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

Share on Social Networks: